Dr. Hans Keirstead is an internationally recognized stem cell expert and entrepreneur in regenerative medicine. He has pioneered therapies for cancer, immune disorders, infectious disease, motor neuron diseases, spinal cord injury, retinal diseases, and age-related immune decline. Each of Dr. Keirstead’s three biotechnology firms was sold to major pharmaceutical companies for 2.5X-9.5X returns to investors after the return of investment capital. Currently, he holds board positions in several leading biotechs, including AIVITA Biomedical, Immunis Inc., and the global Human Immune Project. During his 15-year tenure at the University of California Irvine, Dr. Keirstead mentored over 100 students, published over 150 manuscripts, and granted over 20 patents. He was named one of Discover Magazine’s top 100 scientists and has been featured by Newsweek, WIRED, The New York Times, TIME Magazine, Science, 60 Minutes, PBS, and ABC News Radio. He was awarded the “Top 20 Canadians” Award by the Consul General of Canada, the NIH Solowey award for noted national researcher of the year, and the Cameron Award for the best PhD in the country. Dr. Keirstead received his Ph.D. in neuroscience from the University of British Columbia, Canada, and pursued his postdoctoral research at the University of Cambridge, England.